
The Bristol office of mid-market private equity firm LDC has made an £18m minority investment in global pharmaceutical development organisation TMC Pharma Services. Hampshire-based TMC’s products specialise in innovative treatments for rare diseases and oncology. It has successfully supported more than 150 ‘orphan’ drug designations in the past 10 years...